CN104013893A - Medicament for treating pelvic inflammation - Google Patents

Medicament for treating pelvic inflammation Download PDF

Info

Publication number
CN104013893A
CN104013893A CN201410296724.5A CN201410296724A CN104013893A CN 104013893 A CN104013893 A CN 104013893A CN 201410296724 A CN201410296724 A CN 201410296724A CN 104013893 A CN104013893 A CN 104013893A
Authority
CN
China
Prior art keywords
parts
medicament
fructus
treatment
inflammatory disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410296724.5A
Other languages
Chinese (zh)
Inventor
周宇晨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410296724.5A priority Critical patent/CN104013893A/en
Publication of CN104013893A publication Critical patent/CN104013893A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicament for treating pelvic inflammation. The medicament is prepared from the following traditional Chinese medicines in parts by weight: 20-40 parts of sharpleaf galangal fruit, 10-20 parts of rose, 10-20 parts of fermented soybeans, 10-20 parts of endives, 7-17 parts of myricaria bracteata, 7-17 parts of yellow mustard, 7-17 parts of glossy privet fruit, 7-17 parts of mulberry twigs, 5-13 parts of dandelions, 5-13 parts of hydrocotyle sibthorpioides, 5-13 parts of root of damnacanthus indicus, 5-13 parts of root of cape jasmine fruit, 4-10 parts of root-bark of sessileflower acanthopanax, 4-10 parts of fried atractylodes macrocephala, 4-10 parts of fructus hippophais, 4-10 parts of sandwort, 3-7 parts of mulberries, 3-7 parts of oranges, 3-7 parts of radish seed and 3-7 parts of hupeh fritillary bulb. The medicament has the beneficial effects that the medicament has the advantages of good curative effects on pelvic inflammation, short courses of treatment, small side effects, convenience in use and the like.

Description

A kind of medicament for the treatment of pelvic inflammatory disease
Technical field
The present invention relates to technical field of Chinese medicines, specifically refer to a kind of medicament for the treatment of pelvic inflammatory disease.
Background technology
Pelvic inflammatory disease is the common disease of women, be also a kind of be relatively difficult to radical cure disease, be mainly in menstrual period, puerperal, artificial abortion's pressed on ring, cut open palace produce or gynecologic surgery, antibacterial enters traumatic infection and falls ill.Pelvic inflammatory disease refers to the inflammation of women's anogenital and surrounding tissue thereof, mainly contains endometritis, salpingitis, tubo-ovarian abscess, pelvioperitonitis.Inflammation can be confined to a position, also can involve several positions simultaneously.
At present, it is main that treatment primary disease adopts the antibiosis anti-inflammatory drug of doctor trained in Western medicine more, though the state of an illness is temporarily controlled to some extent, but easily recurrence, and liver, the kidney of the antibiosis anti-inflammatory drug of doctor trained in Western medicine to human body has great harm, administration time elder also likely causes other complication, and doctor trained in Western medicine antibiotic medicine exists, and expensive, drug treatment is long, the problem such as produce effects slowly.
Herbal retention enema method in clinical use for many years, is a reasonable route of administration, is mainly the absorption by intestinal wall, can utilize the semi-transparent permeability of the membrane of intestinal wall to be rapidly absorbed, and cause the therapeutical effect of whole body, especially to the organ closing on, as more remarkable in the effect such as pelvic cavity, abdominal cavity.And, both can be in the while in hospital by nurse operation, also can be after institute, Self-operating at home.
Summary of the invention
In order to make up the deficiencies in the prior art, the invention provides the medicament of a kind of good effect, short treating period, side effect treatment pelvic inflammatory disease little, easy to use.Specifically be achieved by the following technical solution:
Treat a medicament for pelvic inflammatory disease, made by the Chinese crude drug of following weight portion: 20 ~ 40 parts of Fructus Alpiniae Oxyphyllae, 10 ~ 20 parts of the Flos rosae multifloraies, 10 ~ 20 parts of Semen Sojae Preparatums, 10 ~ 20 parts of Herba Cichoriis, 7 ~ 17 parts of Cacumen Myricariae Germanicaes, 7 ~ 17 parts of Semen Sinapiss, 7 ~ 17 parts of Fructus Ligustri Lucidi, 7 ~ 17 parts of Ramulus Moris, 5 ~ 13 parts of Herba Taraxacis, 5 ~ 13 parts of Herba Hydrocotyleses, 5 ~ 13 parts of Radix Damnacanthis, 5 ~ 13 parts of Radix Fructus Gardeniae, 4 ~ 10 parts of Cortex Acanthopanciss, 4 ~ 10 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 4 ~ 10 parts of Fructus Hippophae extractums, 4 ~ 10 parts of sandworts, 3 ~ 7 parts, Fructus Mori, orange 3 ~ 7 parts, 3 ~ 7 parts of Semen Raphanis, 3 ~ 7 parts of Hupeh Fritillary Bulb.
Preferably, treat a medicament for pelvic inflammatory disease, made by the Chinese crude drug of following weight portion: 30 parts of Fructus Alpiniae Oxyphyllae, 15 parts of the Flos rosae multifloraies, 15 parts of Semen Sojae Preparatums, 15 parts of Herba Cichoriis, 12 parts of Cacumen Myricariae Germanicaes, 12 parts of Semen Sinapiss, 12 parts of Fructus Ligustri Lucidi, 12 parts of Ramulus Moris, 9 parts of Herba Taraxacis, 9 parts of Herba Hydrocotyleses, 9 parts of Radix Damnacanthis, 9 parts of Radix Fructus Gardeniae, 7 parts of Cortex Acanthopanciss, 7 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 7 parts of Fructus Hippophae extractums, 7 parts of sandworts, 5 parts, Fructus Mori, orange 5 parts, 5 parts of Semen Raphanis, 5 parts of Hupeh Fritillary Bulb.
The preparation method of the medicament of above-mentioned treatment pelvic inflammatory disease is: the Chinese crude drug that takes described weight portion is put into drug-decocting appliance, adds the clean water that meets drinking water standard, and amount of water is to exceed powder 2-3cm as degree; Enter to decoct front immersion half an hour, make it fully moistening, fully fried in order to medicine juice; After boiling with high heat, use slow fire boiling half an hour instead again, remove medicinal residues, taking liquid obtains the medicament for the treatment of pelvic inflammatory disease.
The Therapeutic Method of the medicament for the treatment of pelvic inflammatory disease of the present invention: before sleeping every night, after emptying stool, urine, get right arm reclining, make buttocks shift near edge of bed, by intravenous transfusion methods, connect transfusion device, Exhaust Gas, transfusion device cuts off syringe needle, and end is coated a small amount of lubricating oil, insert rectum 10 ~ 15cm from anus slowly, medicinal liquid is slowly splashed into.Fluid temperature is advisable with 39 DEG C ~ 41 DEG C, and pressure is low, and liquid level must not exceed 30cm apart from anus, after having filled with, lies up as far as possible.Coloclysis 1 time before sleeping every night, each about 50ml, 2 weeks is 1 course for the treatment of, can fully recover general 2 courses for the treatment of.
The medicament for the treatment of pelvic inflammatory disease of the present invention, its beneficial effect is: have the advantages such as good effect, short treating period, side effect be little, easy to use for pelvic inflammatory disease.
 
detailed description of the invention:
Below in conjunction with embodiment and case, the present invention is further illustrated.
Embodiment 1:
Take Fructus Alpiniae Oxyphyllae 20g, Flos rosae multiflorae 20g, Semen Sojae Preparatum 10g, Herba Cichorii 20g, Cacumen Myricariae Germanicae 7g, Semen Sinapis 17g, Fructus Ligustri Lucidi 7g, Ramulus Mori 17g, Herba Taraxaci 5g, Herba Hydrocotyles 13g, Radix Damnacanthi 5g, Radix Fructus Gardeniae 13g, Cortex Acanthopancis 4g, Rhizoma Atractylodis Macrocephalae (parched) 10g, Fructus Hippophae extractum 4g, sandwort 10g, Fructus Mori 3g, orange 7g, Semen Raphani 3g, Hupeh Fritillary Bulb 7g put into drug-decocting appliance, add the clean water that meets drinking water standard, amount of water is to exceed powder 2-3cm as degree; Enter to decoct front immersion half an hour, make it fully moistening, fully fried in order to medicine juice; After boiling with high heat, use slow fire boiling half an hour instead again, remove medicinal residues, taking liquid obtains the medicament for the treatment of pelvic inflammatory disease.
Embodiment 2:
Take Fructus Alpiniae Oxyphyllae 40g, Flos rosae multiflorae 10g, Semen Sojae Preparatum 20g, Herba Cichorii 10g, Cacumen Myricariae Germanicae 17g, Semen Sinapis 7g, Fructus Ligustri Lucidi 17g, Ramulus Mori 7g, Herba Taraxaci 13g, Herba Hydrocotyles 5g, Radix Damnacanthi 13g, Radix Fructus Gardeniae 5g, Cortex Acanthopancis 10g, Rhizoma Atractylodis Macrocephalae (parched) 4g, Fructus Hippophae extractum 10g, sandwort 4g, Fructus Mori 7g, orange 3g, Semen Raphani 7g, Hupeh Fritillary Bulb 3g put into drug-decocting appliance, add the clean water that meets drinking water standard, amount of water is to exceed powder 2-3cm as degree; Enter to decoct front immersion half an hour, make it fully moistening, fully fried in order to medicine juice; After boiling with high heat, use slow fire boiling half an hour instead again, remove medicinal residues, taking liquid obtains the medicament for the treatment of pelvic inflammatory disease.
Embodiment 3:
Take Fructus Alpiniae Oxyphyllae 30g, Flos rosae multiflorae 15g, Semen Sojae Preparatum 15g, Herba Cichorii 15g, Cacumen Myricariae Germanicae 12g, Semen Sinapis 12g, Fructus Ligustri Lucidi 12g, Ramulus Mori 12g, Herba Taraxaci 9g, Herba Hydrocotyles 9g, Radix Damnacanthi 9g, Radix Fructus Gardeniae 9g, Cortex Acanthopancis 7g, Rhizoma Atractylodis Macrocephalae (parched) 7g, Fructus Hippophae extractum 7g, sandwort 7g, Fructus Mori 5g, orange 5g, Semen Raphani 5g, Hupeh Fritillary Bulb 5g put into drug-decocting appliance, add the clean water that meets drinking water standard, amount of water is to exceed powder 2-3cm as degree; Enter to decoct front immersion half an hour, make it fully moistening, fully fried in order to medicine juice; After boiling with high heat, use slow fire boiling half an hour instead again, remove medicinal residues, taking liquid obtains the medicament for the treatment of pelvic inflammatory disease.
The present invention treats the clinical trial data of pelvic inflammatory disease:
Select Anqing, Anhui Province Patients with Pelvic Inflammatory Disease 105 examples, 28 ~ 50 years old age, 38 years old mean age.Diagnostic criteria: 1, symptom: the conscious soreness of waist repeatedly, lower abdomen pendant pain, leucorrhoea grow in quantity, there is abnormal flavour, heat occasionally occurs together; 2, gynecologial examination: body of uterus tenderness, bilateral attachment area thickens, and tenderness is obvious; 3, B ultrasonic prompting: pelvic hydrops or inflammatory mass.By random this 105 routine patient, be equally divided into three treatment groups, every group of 35 examples.Wherein, treatment group 1 adopts the pharmaceutical treatment of the embodiment of the present invention 1; Treatment group 2 adopts the pharmaceutical treatment of the embodiment of the present invention 2; Treatment group 3 adopts the pharmaceutical treatment of the embodiment of the present invention 3.
Therapeutic Method: before sleeping every night, after emptying stool, urine, get right arm reclining, make buttocks shift near edge of bed, press intravenous transfusion methods, connect transfusion device, Exhaust Gas, transfusion device cuts off syringe needle, end is coated a small amount of lubricating oil, inserts rectum 10 ~ 15cm slowly from anus, and medicinal liquid is slowly splashed into.Fluid temperature is advisable with 39 DEG C ~ 41 DEG C, and pressure is low, and liquid level must not exceed 30cm apart from anus, after having filled with, lies up as far as possible.Coloclysis 1 time before sleeping every night, each about 50ml, 2 weeks is 1 course for the treatment of, treats continuously 2 courses for the treatment of.During treatment, ban use of Chinese medicine, Western medicine or other drug and the therapy of other treatment pelvic inflammatory disease.
Efficacy assessment standard:
Recovery from illness: symptom, sign disappear, and gynecologial examination is normal, and ultrasound diagnosis is normal, nothing recurrence in half a year;
Effective: subjective symptoms disappears or obviously alleviates, in gynecological, examine and check that uterus and adnexa tenderness obviously alleviate but still have, or occasionally have recurrence in half a year;
Invalid: clinical symptoms and sign and treatment are front without much changes.
Therapeutic outcome is in table 1:
Table 1 therapeutic outcome
Conclusion:
In clinical trial process, patient finds no any untoward reaction.Clinical test results shows, medicament of the present invention uses safety, and the total effective rate of pelvic inflammatory disease is reached more than 97.1%, and wherein the medicament of embodiment 3 is best to the curative effect of pelvic inflammatory disease, cure rate is the highest, be the active drug for the treatment of pelvic inflammatory disease, there is well clinical and dissemination.
The above, be only preferred embodiment of the present invention, is not intended to limit protection scope of the present invention.One skilled in the art will appreciate that protection scope of the present invention is as the criterion with appending claims.

Claims (1)

1. treat the medicament of pelvic inflammatory disease for one kind, it is characterized in that, made by the Chinese crude drug of following weight portion: 20 ~ 40 parts of Fructus Alpiniae Oxyphyllae, 10 ~ 20 parts of the Flos rosae multifloraies, 10 ~ 20 parts of Semen Sojae Preparatums, 10 ~ 20 parts of Herba Cichoriis, 7 ~ 17 parts of Cacumen Myricariae Germanicaes, 7 ~ 17 parts of Semen Sinapiss, 7 ~ 17 parts of Fructus Ligustri Lucidi, 7 ~ 17 parts of Ramulus Moris, 5 ~ 13 parts of Herba Taraxacis, 5 ~ 13 parts of Herba Hydrocotyleses, 5 ~ 13 parts of Radix Damnacanthis, 5 ~ 13 parts of Radix Fructus Gardeniae, 4 ~ 10 parts of Cortex Acanthopanciss, 4 ~ 10 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 4 ~ 10 parts of Fructus Hippophae extractums, 4 ~ 10 parts of sandworts, 3 ~ 7 parts, Fructus Mori, orange 3 ~ 7 parts, 3 ~ 7 parts of Semen Raphanis, 3 ~ 7 parts of Hupeh Fritillary Bulb; Preparation method is: the Chinese crude drug that takes described weight portion is put into drug-decocting appliance, adds the clean water that meets drinking water standard, and amount of water is to exceed powder 2-3cm as degree; Enter to decoct front immersion half an hour, make it fully moistening, fully fried in order to medicine juice; After boiling with high heat, use slow fire boiling half an hour instead again, remove medicinal residues, taking liquid obtains the medicament for the treatment of pelvic inflammatory disease.
CN201410296724.5A 2014-06-27 2014-06-27 Medicament for treating pelvic inflammation Pending CN104013893A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410296724.5A CN104013893A (en) 2014-06-27 2014-06-27 Medicament for treating pelvic inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410296724.5A CN104013893A (en) 2014-06-27 2014-06-27 Medicament for treating pelvic inflammation

Publications (1)

Publication Number Publication Date
CN104013893A true CN104013893A (en) 2014-09-03

Family

ID=51431074

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410296724.5A Pending CN104013893A (en) 2014-06-27 2014-06-27 Medicament for treating pelvic inflammation

Country Status (1)

Country Link
CN (1) CN104013893A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110946910A (en) * 2019-12-25 2020-04-03 陶燃 Pharmaceutical composition and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101081285A (en) * 2006-06-02 2007-12-05 向朝晖 Pur Chinese traditional medicine for treating chronic pelvic inflammatory disease and menoxenia disease
US20080031980A1 (en) * 2006-08-02 2008-02-07 Al Rodriguez Curcumin-containing composition, methods of making, and methods of using

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101081285A (en) * 2006-06-02 2007-12-05 向朝晖 Pur Chinese traditional medicine for treating chronic pelvic inflammatory disease and menoxenia disease
US20080031980A1 (en) * 2006-08-02 2008-02-07 Al Rodriguez Curcumin-containing composition, methods of making, and methods of using

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110946910A (en) * 2019-12-25 2020-04-03 陶燃 Pharmaceutical composition and application thereof

Similar Documents

Publication Publication Date Title
CN104189789A (en) Traditional Chinese medicine composition for treating acute infectious jaundice type hepatitis
CN103800622A (en) Traditional Chinese medicament for treating prostatitis
CN102319353B (en) Traditional Chinese drug enema for treating abdominal distension after gynecological operation
CN102526398A (en) Externally-used traditional Chinese medicinal preparation for treating chronic pelvic inflammation
CN102949569B (en) Traditional Chinese medicine composition for treating frequent micturition, urgent urination and micturition pain caused by benign prostatic hyperplasia
CN104258289A (en) Traditional Chinese medicine for treating enteritis
CN102309709B (en) Medicine for treating vesical calculus
CN102293968B (en) Traditional Chinese medicine for preventing and treating hiccup disease
CN103800842A (en) Traditional Chinese medicine composition for treating carcinoma of urinary bladder
CN103550709A (en) Traditional Chinese medicine for treating chronic pelvic inflammation
CN103585585B (en) A kind of Chinese medicine composition for the treatment of choledocholithiasis and preparation method thereof
CN104013784A (en) Medicament for treating pelvic inflammation
CN104013901A (en) Medicament for treating pelvic inflammation
CN104013893A (en) Medicament for treating pelvic inflammation
CN104857454B (en) A kind of traditional Chinese herbal decoction for treating Severe Acute Pancreatitis SAP
CN104042984A (en) Medicament for treating pelvic inflammation
CN104013857A (en) Medicament for treating pelvic inflammation
CN101229238B (en) Chinese traditional medicine preparation for treating prostate disease
CN104398985A (en) Traditional Chinese drug for treating abdominal distension after gynecologic surgery anesthesia
CN102319384B (en) Medicament for treating pelvic inflammation
CN103566003B (en) Pharmaceutical composition for treating cesarean postpartum urinary retention
CN104013809A (en) Medicament for treating pelvic inflammation
CN104013727A (en) Medicament for treating pelvic inflammation
CN104013869A (en) Medicament for treating pelvic inflammation
CN105148050A (en) Traditional Chinese medicinal composition for treating kidney stone

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20140903